Literature DB >> 6306043

Evidence of receptors for thyrotropin-releasing hormone in human prolactin-secreting adenomas.

M Le Dafniet, A M Brandi, D Bression, T Racadot, F Peillon.   

Abstract

Specific receptors for TRH were demonstrated on cellular membranes from 8 out of 10 human PRL-secreting adenomas. One binding site was characterized. The mean (+/- SD) value for the dissociation constant (Kd) from 8 adenomas was 68 +/- 7 nM. The maximal number of binding sites varied from 1 adenoma to another (from 50-1200 fmol/mg protein). In 7 of the 8 patients, there was little or no in vivo plasma PRL response to TRH although receptors for TRH were present on their tumors. It is thus suggested that in vivo absence of stimulatory effect of TRH in human PRL-secreting adenomas is not due to the absence of TRH receptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306043     DOI: 10.1210/jcem-57-2-425

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Perifusion system: its use in the study of the neuroendocrine control of human pituitary tumoral cells.

Authors:  D Joubert; A M Brandi; F Peillon
Journal:  Cell Biol Toxicol       Date:  1992 Jul-Sep       Impact factor: 6.691

Review 2.  Hyperprolactinemia: neuroendocrine and diagnostic aspects.

Authors:  F Camanni; E Ciccarelli; E Ghigo; E E Müller
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

3.  TRH raises cytosolic Ca2+ in human adenomatous lactotrophs.

Authors:  A Spada; F Reza-Elahi; A Lania
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

4.  Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.

Authors:  D M Cook; M A Greer; H Paxton
Journal:  West J Med       Date:  1987-08

Review 5.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.